Work

3109 nab-Paclitaxel (nab-P) plus carboplatin (C) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC): Clinical outcomes by treatment cycle

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)31750-6

Authors: C. Gridelli, L. Li, M. O'Brien, T.J. Ong, R. Pirker, M.A. Socinski, M. Thomas

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2518599270

FWCI:

Cites:

Cited by:

Related to: 10